 |
 |
Dear AIB member The Finance Accounting Research Unit (FARU) at the University of Hertfordshire (UK) in conjunction with the Institute for Chartered Accountants Scotland (ICAS) have issued a research report “UK bio-pharma: Innovation, re-invention and capital at risk”. This report on UK bio-pharma presents a strong case for emergency state funding where it can sensibly prevent a disorderly downsizing of bio-pharma and loss of intangible asset investment. In the medium and long-tem term, this report argues for active and imaginative Government policies that redraw the bio-pharma business model modifying the way in which risk and return are distributed between the different stakeholders involved in a complex and increasingly fragile business model. This report can be downloaded from the ICAS website: http://www.icas.org.uk/site/cms/download/res/Gleadle_Haslam_Report_July_11.pdf Professor Colin Haslam Director Finance Accounting Research Group University of Hertfordshire Hatfield Herts AL10 9AB e-mail [log in to unmask]<mailto:[log in to unmask]> ____ AIB-L is brought to you by the Academy of International Business. For information: http://aib.msu.edu/community/aib-l.asp To post message: [log in to unmask] For assistance: [log in to unmask] AIB-L is a moderated list.